Chinese medical journal

• Latest
• Best
• Search…

• Chinese medical journal · Oct 2023

  Cytomegalovirus antigen-specific T cell immune responses in patients with autoimmune diseases under different cytomegalovirus infection status.

  no abstract available

  read on… or not…

• Chinese medical journal · Oct 2023

  Intervertebral disc generation tissue engineering treatment platform: gelatin-methacryloyl hydrogel composite system.

  no abstract available

  explore further… or not…

• Chinese medical journal · Oct 2023

  Butyrate acts as a G-protein-coupled receptor ligand that prevents high glucose-induced amyloidogenesis in N2a cells through the protein kinase B/glycogen synthase kinase-3β pathway.

  no abstract available

  read more… or not…

• Chinese medical journal · Oct 2023

  Effect of blood sampling management on reducing blood transfusions in very preterm infants.

  no abstract available

  keep going… or not…

• Chinese medical journal · Sep 2023

  Randomized Controlled Trial

  Efficacy and safety of flurbiprofen cataplasms versus loxoprofen sodium cataplasms in knee osteoarthritis: a randomized controlled trial.

  Clinical trial evidence is limited to identify better topical non-steroidal anti-inflammatory drugs (NSAIDs) for treating knee osteoarthritis (OA). We aimed to compare the clinical efficacy and safety of flurbiprofen cataplasms (FPC) with loxoprofen sodium cataplasms (LSC) in treating patients with knee OA. ⋯ This study suggested that FPC is superior to LSC for treating patients with knee OA in pain relief, joint function improvement, and safety profile.

  read more… or not…